Exploring new grounds in clinical optoacoustic imaging

Request a Demo

Assessing changes in tissue chromophore concentration and distribution as an indicator of disease

OAI offers versatile and highly specific contrast from a variety of tissue-intrinsic and extrinsic molecules, including hemoglobin, melanin, lipids, collagen, fluorophores and nanoparticles. This allows for anatomical, functional and molecular imaging within a single modality.

Many diseases come with a change in tissue properties that can be tracked with optoacoustic imaging (OAI). Tissue and disease biomarkers can be assessed in real time, which has allowed clinical trials to demonstrate potential point-of-care value in several disease areas. Portable and cost-effective, OAI could soon provide clinicians new avenues for diagnosis and assessment of therapeutic efficacy.

Inflammatory bowel disease

learn more

Breast cancer

learn more


learn more

Other clinical applications

learn more


Contact us

Don’t hesitate to contact us if you have any questions about our technology, applications or products.

[javascript protected email address] +49 (0) 89 700 7449-0

Contact Request a demo

CAUTION: All products on display are limited by Federal law to research or investigational use. IRB and FDA approval for research and clinical investigations may apply. Further device information is restricted to research professionals.